<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations and diagnosis of peripheral spondyloarthritis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Astrid van Tubergen, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joachim Sieper, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Peripheral spondyloarthritis (SpA) is the term used to describe patients with features of SpA whose symptoms and findings are predominantly or entirely peripheral rather than axial; these features include arthritis, which is predominantly of the lower limbs and/or asymmetric; enthesitis; and dactylitis. Patients included in this category, who have these findings in common, include those with psoriatic arthritis (PsA), reactive arthritis, SpA related to inflammatory bowel disease (IBD), and the subset of patients with such manifestations who do not meet established definitions for these three forms of SpA. Patients with ankylosing spondylitis and non-radiographic axial SpA are not included within the peripheral SpA category, even if peripheral manifestations of musculoskeletal involvement are also present. Even though the Assessment of SpondyloArthritis International Society (ASAS) classifies SpA into axial and peripheral groups [<a href="#rid1">1,2</a>], this binary division seldom exists in practice because there is considerable overlap between axial and peripheral SpA [<a href="#rid3">3</a>].</p><p>Within the peripheral SpA subset, a clear distinction between the clinically defined subsets is often lacking. As examples, in a considerable number of patients, skin manifestations of psoriasis do not occur until after the manifestation of rheumatic symptoms; preceding infections may be clinically asymptomatic (eg, with Chlamydia); and IBD can also be asymptomatic when patients present with musculoskeletal symptoms [<a href="#rid4">4,5</a>].</p><p>An overview of the clinical manifestations, diagnosis, and differential diagnosis of peripheral SpA in adults will be presented here, which is focused upon those adult patients with peripheral SpA who do not have psoriasis, IBD, or reactive arthritis. The treatment of peripheral SpA; the classification of SpA; and the clinical manifestations, diagnosis, and treatment of ankylosing spondylitis, non-radiographic axial SpA, PsA, reactive arthritis, arthritis associated with IBD, and SpA in children are discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/105691.html" rel="external">"Treatment of peripheral spondyloarthritis"</a> and  <a class="medical medical_review" href="/z/d/html/95962.html" rel="external">"Overview of the clinical manifestations and classification of spondyloarthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">"Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">"Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6421.html" rel="external">"Spondyloarthritis in children"</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7790.html" rel="external">"Treatment of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The global prevalence of spondyloarthritis (SpA), including axial and peripheral SpA, has been estimated at approximately 1 percent [<a href="#rid6">6,7</a>]. In a 2019 cross-sectional study of 2423 SpA patients without associated psoriasis from a wide range of countries, only 6 percent of these SpA patients showed a peripheral arthritis predominant distribution [<a href="#rid8">8</a>]. Study results vary widely between different populations and ethnic groups, which can at least partly be explained by differences in the prevalence of human leukocyte antigen B27 (HLA-B27). Other important contributors to these differences are heterogeneity in the populations analyzed, variation in the criteria used for case definition, and the number of participants approached and included in each study.</p><p>The main manifestation of peripheral SpA is arthritis (96 to 98 percent), followed by enthesitis (41 to 48 percent) and dactylitis (40 to 49 percent) [<a href="#rid3">3</a>]. Peripheral SpA has an equal sex distribution [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H61262047"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of peripheral spondyloarthritis (SpA) include most of the features common to other forms of SpA; only some of these may be present in a given patient. Those of greatest importance, as reflected by the classification criteria for peripheral SpA, include the three peripheral musculoskeletal manifestations, which are arthritis (predominantly of the lower extremities and/or asymmetric), enthesitis, and dactylitis [<a href="#rid1">1</a>]. Of similar importance are other features, including uveitis and the presence of psoriasis or inflammatory bowel disease (IBD; Crohn's disease/ulcerative colitis) or a history of an infection that may trigger reactive arthritis. Other features that may be present, but which are of lesser importance in the classification scheme, are a history of inflammatory back pain (IBP) in the past and a family history of SpA, which is defined as the presence in a first- or second-degree relative of SpA, uveitis, reactive arthritis, psoriasis, or IBD. (See <a class="local">'Musculoskeletal features'</a> below and <a class="local">'Inflammatory eye disease'</a> below and <a class="local">'Inflammation of the bowel mucosa'</a> below and <a class="local">'Psoriasis'</a> below.)</p><p>Although the clinical picture is often very similar, patients with psoriasis, IBD, and reactive arthritis each do have some features specific for their diseases which are described in detail separately [<a href="#rid10">10-12</a>]. (See  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Clinical manifestations'</a>.) </p><p class="headingAnchor" id="H61262077"><span class="h2">Musculoskeletal features</span><span class="headingEndMark"> — </span>The three peripheral musculoskeletal manifestations characteristic of peripheral SpA are peripheral arthritis, enthesitis, and dactylitis. The other musculoskeletal manifestation that may be present is back pain, including IBP, current or in the past. The back pain, however, is not a dominant feature compared with the peripheral symptoms and findings [<a href="#rid13">13</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral arthritis</strong> – Peripheral arthritis is present in most patients with peripheral SpA. The peripheral arthritis in SpA is often chronic but can be self-limiting and predominantly involves the lower extremities, especially the knees and ankles [<a href="#rid1">1,14,15</a>]. However, any joint can be involved. Arthritis is asymmetric in approximately 70 percent of patients and often affects only one to three joints [<a href="#rid1">1</a>]. A small percentage of patients have involvement of four or more joints. When compared with other rheumatic diseases, the sensitivity and specificity of asymmetric oligoarthritis for SpA were found to be 41 and 87 percent, respectively [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enthesitis (enthesopathy)</strong> – Enthesitis is a hallmark clinical feature of SpA (and also of psoriatic arthritis) [<a href="#rid16">16</a>]. Enthesitis (or enthesopathy) refers to inflammation around the enthesis, which is the site of insertion of ligaments, tendons, joint capsule, or fascia to the surface of the bone, and is relatively specific to SpA [<a href="#rid17">17</a>]. Although enthesitis is less common than peripheral arthritis, it is still present in approximately 60 percent of patients [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1">The most noticeable clinical manifestation of enthesitis is swelling at the heels, either at the insertion of the Achilles tendon  (<a class="graphic graphic_figure graphicRef81198" href="/z/d/graphic/81198.html" rel="external">figure 1</a> and <a class="graphic graphic_picture graphicRef96430" href="/z/d/graphic/96430.html" rel="external">picture 1</a>) or at the insertion of the plantar fascia ligament into the calcaneus [<a href="#rid14">14</a>]. It is usually associated with severe pain and tenderness.</p><p></p><p class="bulletIndent1">During physical examination, the patient often has difficulty walking on the heels when barefoot. Swelling at the side of the Achilles tendon may be appreciated when the patient is observed in the standing position from behind. On palpation, there is tenderness at the sites of insertion of the Achilles tendon and/or of the plantar fascia on the calcaneus. Other sites of enthesitis that do not become visibly swollen, but which can be tender, include those at the iliac crests, greater trochanters, epicondyles at the elbows, quadriceps insertion into superior border of patella, patellar ligament insertion into the inferior pole of the patella or into the tibial tuberosity, costochondral junctions at the sternum, humeral tuberosities, manubrial-sternal joints, occiput, and spinous processes [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1">The presence of enthesitis detected by tenderness alone might require imaging for confirmation [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dactylitis (sausage digits)</strong> – Dactylitis, also known as sausage toe or sausage finger  (<a class="graphic graphic_picture graphicRef61696" href="/z/d/graphic/61696.html" rel="external">picture 2</a>), is present in approximately 17 percent of patients with peripheral SpA without psoriasis [<a href="#rid8">8</a>]. Because it is more often found in association with psoriasis, presence of dactylitis heightens the suspicion of psoriatic arthritis (PsA). Unlike synovitis, in which swelling is confined to the joints, with dactylitis, the entire digit is swollen. Joints do not show the discrete palpable fusiform swelling of synovitis, and there may be surprisingly little pain or tenderness. The diffuse swelling arises from flexor tendon, sheath, and marked adjacent soft tissue involvement. Although dactylitis is a characteristic manifestation of SpA, it may also be seen in other conditions, including tuberculosis, syphilis, sarcoidosis, sickle cell disease, and tophaceous gout [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inflammatory back pain</strong> – A pattern of back discomfort referred to as IBP is characteristic of axial SpA, but by definition is not the predominant feature of peripheral SpA, although up to 21 percent of patients with predominantly peripheral symptoms have a history of back pain in the past that is consistent with IBP [<a href="#rid20">20</a>]. However, IBP is considered present in patients with at least four of the following five features: an insidious onset of back pain, onset before the age of 40 years, improvement with exercise, a lack of improvement with rest, and pain at night [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">"Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Low back pain and neck pain'</a>.)</p><p></p><p class="bulletIndent1">Subclinical spinal disease is also frequently present in patients with peripheral SpA. In a clinical trial, including patients with early SpA, 35 percent had sacroiliitis on magnetic resonance imaging (MRI), while only 12 percent reported having back pain [<a href="#rid22">22</a>].</p><p></p><p class="headingAnchor" id="H61262641"><span class="h2">Inflammatory eye disease</span><span class="headingEndMark"> — </span>Ocular inflammatory diseases, including conjunctivitis and anterior uveitis, may occur but are uncommon in patients with peripheral SpA [<a href="#rid23">23-25</a>]. Conjunctivitis is typically transient with symptoms subsiding within a few weeks. A more serious problem is anterior uveitis (iritis), which is mostly associated with human leukocyte antigen B27 (HLA-B27) positivity [<a href="#rid24">24</a>]. The initial attack of uveitis is usually acute and unilateral and may be the presenting problem. Patients typically note redness, pain, and photophobia. Although ocular inflammation often responds to topical therapy, permanent impairment of vision is possible if treatment is unsuccessful [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/5592.html" rel="external">"Uveitis: Treatment"</a>.)</p><p>An accurate diagnosis and optimal management of uveitis requires slit lamp examination by an ophthalmologist or other expert in uveitis. Episodes of iritis can last several months but usually do not run a chronic course or necessarily parallel the course of arthritis. (See  <a class="medical medical_review" href="/z/d/html/5581.html" rel="external">"Uveitis: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H61262647"><span class="h2">Inflammation of the bowel mucosa</span><span class="headingEndMark"> — </span>Bowel mucosal inflammation associated with peripheral SpA can be symptomatic, as in patients with IBD, or can be asymptomatic. Approximately 10 percent of patients with IBD present with signs or symptoms of SpA [<a href="#rid11">11,26</a>]. In patients with IBD, the peripheral arthritis can be associated with skin, oral mucosal, and ocular manifestations of IBD. Peripheral arthritis occurs more frequently in Crohn disease than in ulcerative colitis [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"</a> and  <a class="medical medical_review" href="/z/d/html/7792.html" rel="external">"Pathogenesis of spondyloarthritis"</a>.)</p><p>Up to two-thirds of patients with SpA have inflammatory lesions of the bowel mucosa, but these are frequently clinically silent [<a href="#rid28">28</a>]. The prevalence of gut inflammation is higher in patients with peripheral arthritis than in those with axial involvement. Remission of joint inflammation is associated with disappearance of gut inflammation, while persistence of peripheral arthritis is usually accompanied by persistence of bowel inflammation [<a href="#rid29">29,30</a>].</p><p class="headingAnchor" id="H102212580"><span class="h2">Psoriasis</span><span class="headingEndMark"> — </span>PsA can present with any of several different patterns of clinical manifestations. Some experts have suggested that all forms of arthritis associated with psoriasis should be classified as SpA, but this remains a matter of debate. Only those patients with PsA who present with arthritis that is predominantly of the lower limbs and/or asymmetric, enthesitis, or dactylitis should generally be regarded as having a peripheral SpA, while patients with polyarthritis predominantly of the hands should not [<a href="#rid10">10,31</a>]. Arthritis associated with psoriasis is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Diagnosis'</a>.)</p><p><strong>Reactive arthritis</strong> – Reactive arthritis is characterized by a history or evidence of an episode of a triggering infection that precedes the onset of musculoskeletal symptoms. Reactive arthritis is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis"</a>.)</p><p class="headingAnchor" id="H61262955"><span class="h1">LABORATORY FINDINGS</span><span class="headingEndMark"> — </span>There are no laboratory findings that are pathognomonic for peripheral spondyloarthritis (SpA) or SpA in general, although individuals with human leukocyte antigen B27 (HLA-B27) are at increased risk for SpA, and, in some patients, acute phase reactants may be elevated. Occasionally, laboratory tests can identify microbial infections which can trigger reactive arthritis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>HLA-B27</strong> - HLA-B27 is present in approximately half of the patients with reactive arthritis and peripheral SpA without other associated disease, but is present in a lower frequency in patient with psoriatic arthritis (PsA) and arthritis associated with inflammatory bowel disease (IBD) [<a href="#rid1">1,15</a>]. A positive HLA-B27 by itself is supportive but not diagnostic of SpA, since a significant proportion of subjects in the general population are also positive. All features of SpA can also occur in HLAB27-negative patients, although acute anterior uveitis is rare in this population [<a href="#rid32">32-34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infection</strong> – Specific infectious diseases are best established as a trigger of SpA for reactive arthritis. (See  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Definition'</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Preceding infection'</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Acute inflammatory changes'</a> and  <a class="medical medical_review" href="/z/d/html/7792.html" rel="external">"Pathogenesis of spondyloarthritis"</a>.)</p><p></p><p class="bulletIndent1">SpA, predominantly of the peripheral type, can occur in patients infected with the human immunodeficiency virus (HIV), despite the immunodeficiency [<a href="#rid35">35-37</a>]. The clinical manifestations of peripheral SpA in HIV-infected patients are similar to those seen in HIV-negative individuals [<a href="#rid38">38</a>]. In areas of the world in which HIV infections are highly prevalent, SpA may be common regardless of the presence of HLA-B27. In one study among 702 consecutive patients attending an arthritis clinic in Zambia, where there is a relatively high prevalence of HIV, 395 patients were diagnosed as having SpA [<a href="#rid39">39,40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute phase reactants</strong> - Acute phase reactants, including the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are often increased, although normal ESR and CRP levels do not exclude the presence of SpA. Increased levels of CRP are present in approximately 40 percent of peripheral SpA patients who do not have psoriasis [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H61263419"><span class="h1">IMAGING</span><span class="headingEndMark"> — </span>Sacroiliitis on imaging, detected by either plain radiography or MRI, can be present in patients with peripheral spondyloarthritis (SpA), even if patients do not complain about typical back pain [<a href="#rid22">22</a>]. The other imaging findings depend upon the form of peripheral SpA that is present. Radiographs of peripheral joints, including those with inflammatory bowel diseases (IBD), are often normal [<a href="#rid41">41</a>]; a particular exception is patients with more advanced psoriatic arthritis (PsA). (See  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Imaging abnormalities'</a> and  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Radiographic findings'</a> and  <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">"Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Musculoskeletal imaging'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral joints</strong> – Plain radiographs of peripheral joints are often unremarkable and do not show the same type of erosions seen in rheumatoid arthritis (RA). In patients with PsA, both osteo-proliferative and osteo-destructive lesions may be seen not only in the same patient, but also in the same joint. Other typical radiologic changes in PsA include lysis of the terminal phalanges; fluffy periostitis, as well as new bone formation, at the site of enthesitis; gross destruction of isolated joints; "pencil-in-cup" appearance; and the occurrence of both joint lysis and ankylosis in the same patient. The distal interphalangeal joints are frequently the first to be affected, followed by the proximal interphalangeal joints, the metacarpal phalangeal joints, and the wrists. (See  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Entheses</strong> – Fluffy erosions can sometimes be seen using plain radiography in areas of enthesitis, such as the heels, although these findings are not specific for SpA [<a href="#rid42">42</a>]. Studies using B-mode ultrasound with power Doppler capability (PDUS) can demonstrate abnormal vascularization at the entheses in patients with SpA in the hands of experienced operators [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/1832.html" rel="external">"Musculoskeletal ultrasonography: Clinical applications", section on 'Entheses'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dactylitis</strong> – Plain radiographs of dactylitis in patients with SpA do not show changes affecting the bone itself, which distinguishes SpA-related dactylitis from the swollen digits of dactylitis that may be seen in tuberculosis, sarcoid, sickle cell disease, and syphilis [<a href="#rid43">43</a>] (see <a class="local">'Differential diagnosis'</a> below). The MRI and ultrasound change common to the dactylitis of SpA is flexor tenosynovitis [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Axial skeleton</strong> – Findings of sacroiliitis by plain radiography or MRI may be present in up to 50 percent of patients with peripheral SpA, even in those with only several weeks of disease [<a href="#rid1">1,44</a>]. Axial findings in patients with PsA and the arthritis of IBD may be more asymmetric, especially in those who are human leukocyte antigen B27 (HLA-B27)-negative, than is typically seen in ankylosing spondylitis. The radiographic findings of axial SpA are described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7785.html" rel="external">"Clinical manifestations of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Musculoskeletal imaging'</a> and  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Imaging findings'</a> and  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Imaging abnormalities'</a> and  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Radiographic findings'</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">DIAGNOSIS AND CLASSIFICATION</span></p><p class="headingAnchor" id="H150836809"><span class="h2">Diagnostic strategy</span><span class="headingEndMark"> — </span>The diagnosis of peripheral spondyloarthritis (SpA) is entirely clinical. There are no established diagnostic algorithms or criteria for peripheral SpA. However, although the diagnosis cannot be made using a checklist such as that used for classification (eg, for epidemiologic or clinical studies and trials), the Assessment of SpondyloArthritis International Society (ASAS) classification criteria for peripheral SpA provide a general guide that identifies the important clinical and laboratory characteristics typically present that help to identify patients with the condition (see <a class="local">'Use of classification criteria'</a> below).<em> </em>There are four principle elements that should be weighed collectively to establish the diagnosis:</p><p class="bulletIndent1"><span class="glyph">●</span>Identification of characteristic clinical findings, such as asymmetric and/or oligoarticular large-joint arthritis, enthesitis, or dactylitis, and other associated features that may be present (eg, anterior uveitis, family history of SpA-related disease). (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Laboratory findings'</a> above and <a class="local">'Imaging'</a> above and <a class="local">'Use of classification criteria'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Identification of features of one of the subgroups of peripheral SpA (eg, psoriasis, Crohn disease/ulcerative colitis, or reactive arthritis). (See <a class="local">'Peripheral SpA subgroups'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exclusion of conditions that may mimic peripheral SpA (see <a class="local">'Differential diagnosis'</a> below). This is a very important step in the diagnostic strategy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ongoing monitoring of patients during follow-up for additional features of peripheral SpA or of conditions in the differential diagnosis of peripheral SpA to allow for a more definitive diagnosis.</p><p></p><p>Patients suspected of having a peripheral SpA based upon the presence of one or more features of the disease should undergo a thorough medical history and physical examination with particular attention to manifestations that are common to the various subgroups of peripheral SpA (see <a class="local">'Clinical manifestations'</a> above), which distinguish patients in one from another subgroup (see <a class="local">'Peripheral SpA subgroups'</a> below), and those that would help to identify patients with one of the disorders important in the differential diagnosis. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Testing for human leukocyte antigen B27 (HLA-B27) may be useful in some patients, depending upon the extent to which additional findings are present. Its presence alone is not diagnostic, and its absence does not exclude the diagnosis. Other laboratory testing, including C-reactive protein (CRP; or alternatively an erythrocyte sedimentation rate [ESR]) should be obtained in patients suspected of peripheral SpA, but both tests are often normal, which does not exclude the diagnosis.</p><p>Other laboratory testing (complete blood count, renal and liver chemistries) may be useful in the evaluation for the presence of potential comorbidities, especially when further treatment is planned, but are often not required for establishing the diagnosis.</p><p>Patients with ankylosing spondylitis and non-radiographic axial SpA are not included within the diagnostic category of peripheral SpA, even if peripheral manifestations of musculoskeletal involvement are also present [<a href="#rid1">1,2</a>]. However, imaging of the sacroiliac joints may be useful in the diagnosis of peripheral SpA to determine if asymptomatic disease is present that may support the diagnosis of a SpA.</p><p>An initial estimate of the likelihood of disease also depends upon whether features suggesting an alternative diagnosis are present, and additional testing may also be obtained depending upon the differential diagnosis generated from the presenting features and other abnormalities that may be identified.</p><p class="headingAnchor" id="H89275658"><span class="h2">Use of classification criteria</span><span class="headingEndMark"> — </span>There are two sets of classification criteria for SpA that have been developed by ASAS, one for those presenting with axial involvement and the other for those presenting with predominantly peripheral involvement [<a href="#rid1">1,45</a>]. The classification criteria were developed for use in epidemiologic and clinical research. They are not meant for diagnosis as they lack sufficient sensitivity and specificity to be used as the only diagnostic tool in clinical practice [<a href="#rid46">46</a>]. However, the classification criteria for peripheral SpA include several important clinical and laboratory characteristics typically for peripheral SpA, and therefore it may help identifying patients with the condition. (See <a class="local">'Diagnostic strategy'</a> above and  <a class="medical medical_review" href="/z/d/html/95962.html" rel="external">"Overview of the clinical manifestations and classification of spondyloarthritis", section on 'Axial SpA'</a>.)</p><p>The ASAS criteria emphasize the role of presenting symptoms in the identification of patients with peripheral SpA and the distinction between patients with axial SpA and peripheral SpA. There are two steps in the algorithm for classifying peripheral SpA:</p><p>The entry step is that the patient should have, <strong>at the time of being seen</strong>, at least one of the following three findings diagnosed by a clinician:</p><p class="bulletIndent1"><span class="glyph">●</span>Arthritis (compatible with SpA, typically asymmetric and/or predominantly of the lower extremities)</p><p class="bulletIndent1"><span class="glyph">●</span>Enthesitis (at any site)</p><p class="bulletIndent1"><span class="glyph">●</span>Dactylitis</p><p></p><p>In addition to the entry criteria, patients need to have elements from one of two groups of features, termed Group A and Group B. The features in Group A and B do not necessarily have to be present at the time the patient is being seen. A criterion used to satisfy the entry step may not be counted twice. If the patient satisfies the entry criteria, the patient should show at least one of the features of SpA in Group A (below) or at least two other of the features of SpA in Group B (below):</p><p class="bulletIndent1"><span class="glyph">●</span>Group A SpA features:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anterior uveitis (present or past, documented by an ophthalmologist)</p><p class="bulletIndent2"><span class="glyph">•</span>Psoriasis (present or past, documented by a clinician)</p><p class="bulletIndent2"><span class="glyph">•</span>Crohn disease or ulcerative colitis (present or past, documented by a clinician)</p><p class="bulletIndent2"><span class="glyph">•</span>Preceding infection (urethritis/cervicitis or diarrhea within one month before onset of arthritis/enthesitis/dactylitis)</p><p class="bulletIndent2"><span class="glyph">•</span>HLA-B27</p><p class="bulletIndent2"><span class="glyph">•</span>Sacroiliitis on imaging (bilateral grade 2 to 4 or unilateral grade 3 to 4 on plain radiography or active sacroiliitis on MRI) (see  <a class="medical medical_review" href="/z/d/html/7786.html" rel="external">"Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults", section on 'Imaging studies'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Group B SpA features:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arthritis (present or past, documented by a clinician)</p><p class="bulletIndent2"><span class="glyph">•</span>Enthesitis (present or past, documented by a clinician)</p><p class="bulletIndent2"><span class="glyph">•</span>Dactylitis (present or past, documented by a clinician)</p><p class="bulletIndent2"><span class="glyph">•</span>Inflammatory back pain (IBP) in the past (classify using axial SpA criteria if present at the time of evaluation)</p><p class="bulletIndent2"><span class="glyph">•</span>Family history of SpA (first- or second-degree relative with ankylosing spondylitis, psoriasis, acute uveitis, reactive arthritis, or inflammatory bowel disease [IBD])</p><p></p><p>The ASAS criteria are <strong>inclusive</strong> of disorders such as psoriatic arthritis (PsA), IBD-related arthritis, and reactive arthritis. (See <a class="local">'Peripheral SpA subgroups'</a> below.)</p><p class="headingAnchor" id="H89275982"><span class="h2">Peripheral SpA subgroups</span><span class="headingEndMark"> — </span>A diagnosis of peripheral SpA can be made in patients with other defined medical conditions characterized in part by peripheral arthritis, dactylitis, and enthesitis; another subgroup of peripheral SpA is composed of patients without an associated illness (see <a class="local">'Diagnosis and classification'</a> above and <a class="local">'Use of classification criteria'</a> above). Subgroups of patients with peripheral SpA include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psoriatic arthritis</strong> – A subset of patients with PsA can have features characteristic of peripheral SpA (arthritis predominantly of the lower limbs and/or asymmetric arthritis; enthesitis; or dactylitis), although many other PsA patients present with an arthritis not typical for peripheral SpA (eg, polyarthritis predominantly of the hands or axial SpA). The diagnosis of PsA is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reactive arthritis</strong> – Most patients with reactive arthritis have findings consistent with peripheral SpA following a gastrointestinal or urogenital infection. The diagnosis of reactive arthritis is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arthritis associated with inflammatory bowel disease</strong> – Some patients with arthritis associated with IBD have features consistent with peripheral SpA, but axial symptoms are also frequently reported. The diagnosis is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases"</a> and  <a class="medical medical_review" href="/z/d/html/7787.html" rel="external">"Clinical manifestations and diagnosis of arthritis associated with inflammatory bowel disease and other gastrointestinal diseases", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral SpA without an associated illness</strong> – A subset of patients with peripheral SpA do not have features of one of the well-defined disease subgroups. Patients whose disease manifestations could not be classified as a specific disease entity were previously classified as having undifferentiated SpA (USpA). However, USpA is frequently mistakenly understood to be a mild and ill-defined or early stage of ankylosing spondylitis or PsA, whereas increasing evidence supports the concept that SpA is better seen, with respect to pathophysiology, clinical findings, and treatment, as a single disease with different phenotypes [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/z/d/html/7792.html" rel="external">"Pathogenesis of spondyloarthritis"</a>.)</p><p></p><p class="bulletIndent1">The term "undifferentiated SpA" has disappeared with the wider acceptance of the ASAS classification criteria and their underlying assumptions, as most patients with conditions historically described as USpA can now be classified as having either peripheral SpA or non-radiographic axial SpA, depending upon the predominant features of their disease.</p><p></p><p class="headingAnchor" id="H35"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Several conditions that may also cause peripheral arthritis or heel swelling and sausage-like digits are described here and should be considered in the differential diagnosis of peripheral spondyloarthritis (SpA) and excluded as part of the diagnostic evaluation. Most can be distinguished from peripheral SpA based upon the clinical history and examination, but occasionally additional laboratory testing or imaging are required, depending upon the presenting symptoms and findings. The broader differential diagnoses of polyarticular or monoarticular joint pains are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1821.html" rel="external">"Evaluation of the adult with polyarticular pain"</a> and  <a class="medical medical_review" href="/z/d/html/1820.html" rel="external">"Monoarthritis in adults: Etiology and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/190.html" rel="external">"Achilles tendinopathy and tendon rupture"</a> and  <a class="medical medical_review" href="/z/d/html/7762.html" rel="external">"Plantar fasciitis"</a> and  <a class="medical medical_review" href="/z/d/html/16375.html" rel="external">"Non-Achilles ankle tendinopathy"</a>.)</p><p>The major conditions that should be considered in the differential diagnosis of peripheral SpA include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rheumatoid arthritis</strong> – Inflammatory arthritis in peripheral joints characterizes both rheumatoid arthritis (RA) and SpA. Patients with RA typically experience symmetric polyarthritis of the small joints as a major component of their joint involvement, while the arthritis in peripheral SpA is more frequently asymmetric and oligoarticular and often predominantly affects the lower extremities. Other features of peripheral SpA, such as dactylitis and enthesitis, are not seen of RA, and rheumatoid factor or anti-citrullinated peptide antibodies are uncommon in peripheral SpA compared with RA. (See  <a class="medical medical_review" href="/z/d/html/7502.html" rel="external">"Clinical manifestations of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7504.html" rel="external">"Diagnosis and differential diagnosis of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/z/d/html/7784.html" rel="external">"Clinical manifestations and diagnosis of psoriatic arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Osteoarthritis</strong> – Both peripheral SpA and osteoarthritis (OA) may be characterized by pain and swelling in the knees. However other features typical of SpA but not OA, such as inflammatory synovial fluid, enthesitis, dactylitis, evidence of sacroiliitis, and elevated C-reactive protein (CRP) levels; or of OA but not SpA, such as joint space narrowing without erosions, help to distinguish these conditions from each other. (See  <a class="medical medical_review" href="/z/d/html/105723.html" rel="external">"Clinical manifestations and diagnosis of osteoarthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gout</strong> – Both SpA and gout can present as an acute monoarthritis or oligoarthritis predominantly of the lower limbs or with sausage-like digits [<a href="#rid47">47</a>]. The diagnosis of gout can be confirmed by finding monosodium urate crystals on examination of the synovial fluid and the characteristic pattern of acute then remitting crystal arthritis seen in patients with gout. However, SpA and gout can coexist, and SpA associated with psoriasis (psoriatic arthritis [PsA]) can be associated with hyperuricemia. The identification of other features of SpA is important in establishing the diagnosis of SpA in such patients. (See  <a class="medical medical_review" href="/z/d/html/1667.html" rel="external">"Clinical manifestations and diagnosis of gout"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Achilles tendinopathy, non-Achilles ankle tendinopathy, plantar fasciitis, and sequelae of ankle sprain</strong> – All these conditions can cause pain and/or swelling around the ankle and heel, as can peripheral SpA with enthesitis. A history of acute trauma or repetitive injury is often present in these other conditions and other features of SpA are generally lacking. However, in some patients a thorough evaluation for other features of peripheral SpA and monitoring of the response to therapies and of the clinical status over time are required to distinguish an underlying inflammatory peripheral SpA from injury or overuse as the primary cause of such symptoms and findings. (See  <a class="medical medical_review" href="/z/d/html/190.html" rel="external">"Achilles tendinopathy and tendon rupture"</a> and  <a class="medical medical_review" href="/z/d/html/7762.html" rel="external">"Plantar fasciitis"</a> and  <a class="medical medical_review" href="/z/d/html/16375.html" rel="external">"Non-Achilles ankle tendinopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dactylitis of sarcoidosis and sickle cell disease</strong> – The appearance of sausage digits in sarcoidosis, sickle cell disease, and tuberculosis of the digits can be indistinguishable from those of SpA [<a href="#rid47">47</a>]. However, these conditions can each generally be distinguished from peripheral SpA on history and examination, based upon the major clinical findings that characterize these respective disorders, and by plain radiography, as characteristic changes are often seen in the bone in these conditions, unlike SpA-related dactylitis [<a href="#rid43">43</a>]. (See <a class="local">'Imaging'</a> above and  <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/5586.html" rel="external">"Sarcoid myopathy"</a> and  <a class="medical medical_review" href="/z/d/html/5583.html" rel="external">"Sarcoid arthropathy"</a> and  <a class="medical medical_review" href="/z/d/html/7119.html" rel="external">"Overview of the clinical manifestations of sickle cell disease"</a> and  <a class="medical medical_review" href="/z/d/html/5919.html" rel="external">"Acute and chronic bone complications of sickle cell disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lyme arthritis</strong> – Both Lyme arthritis and SpA can present with oligoarthritis, often of the knee or other large joints, and patients often do not remember the preceding tick bite and/or the cutaneous eruption of erythema migrans. Arthritis presenting in a geographic location in which Lyme disease is endemic should raise suspicion for this diagnosis, which can generally be established based upon serologic studies for Lyme borreliosis. Additionally, other findings typical of peripheral SpA are usually absent in patients with Lyme disease. (See  <a class="medical medical_review" href="/z/d/html/7894.html" rel="external">"Musculoskeletal manifestations of Lyme disease"</a> and  <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fibromyalgia</strong> – The tender points of fibromyalgia might be mistaken for enthesitis. However, true inflammatory arthritis and other signs of SpA are generally absent in these patients unless overlapping diagnoses are present. (See  <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">"Clinical manifestations and diagnosis of fibromyalgia in adults", section on 'Physical findings'</a>.)</p><p></p><p class="headingAnchor" id="H3474009749"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118770.html" rel="external">"Society guideline links: Spondyloarthritis"</a>.)</p><p class="headingAnchor" id="H38"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/518.html" rel="external">"Patient education: Reactive arthritis (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/577.html" rel="external">"Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/515.html" rel="external">"Patient education: Psoriatic arthritis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H39"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral spondyloarthritis (SpA) refers to a group of diseases that share certain clinical features; all patients with peripheral SpA have one or more of the following: peripheral arthritis, enthesitis, and/or dactylitis. In addition, patients with peripheral SpA may also have one or more of the following: psoriasis, inflammatory bowel disease (IBD), anterior uveitis, an association with prior or ongoing infection, sacroiliitis by imaging, a past history of axial pain, a family history of SpA, and/or the human leukocyte antigen B27 (HLA-B27). (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Laboratory findings'</a> above and <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of peripheral SpA is made in a patient with one of the characteristic musculoskeletal findings (peripheral arthritis, enthesitis, or dactylitis), usually with one or more other characteristically associated findings listed above, and, very importantly, after exclusion of conditions that may strongly resemble peripheral SpA.</p><p></p><p class="bulletIndent1">Patients should be monitored during follow-up for additional elements suggesting SpA or features of a condition in the differential diagnosis. The Assessment of SpondyloArthritis International Society (ASAS) classification criteria for SpA provide helpful guidance but should not be used as a diagnostic tool. Diagnosis cannot be made by a checklist of items. (See <a class="local">'Diagnosis and classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The differential diagnosis of peripheral SpA includes rheumatoid arthritis (RA), osteoarthritis (OA), gout, Achilles tendinopathy, non-Achilles ankle tendinopathy, plantar fasciitis, ankle sprain and its sequelae, dactylitis of sarcoidosis and sickle cell disease, Lyme disease, and fibromyalgia. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H1003006779"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges David Yu, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70:25.</a></li><li><a class="nounderline abstract_t">Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 2005; 44:1483.</a></li><li><a class="nounderline abstract_t">Carron P, De Craemer AS, Van den Bosch F. Peripheral spondyloarthritis: a neglected entity-state of the art. RMD Open 2020; 6.</a></li><li><a class="nounderline abstract_t">Carter JD, Gérard HC, Espinoza LR, et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009; 60:1311.</a></li><li><a class="nounderline abstract_t">Van Praet L, Van den Bosch FE, Jacques P, et al. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 2013; 72:414.</a></li><li><a class="nounderline abstract_t">Akkoc N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr Rheumatol Rep 2008; 10:371.</a></li><li><a class="nounderline abstract_t">Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken) 2012; 64:905.</a></li><li><a class="nounderline abstract_t">López-Medina C, Moltó A, Dougados M. Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study. J Rheumatol 2020; 47:211.</a></li><li><a class="nounderline abstract_t">del Río-Martínez P, Navarro-Compán V, Díaz-Miguel C, et al. Similarities and differences between patients fulfilling axial and peripheral ASAS criteria for spondyloarthritis: Results from the Esperanza Cohort. Semin Arthritis Rheum 2016; 45:400.</a></li><li><a class="nounderline abstract_t">Gladman DD. Editorial: What is peripheral spondyloarthritis? Arthritis Rheumatol 2015; 67:865.</a></li><li><a class="nounderline abstract_t">Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2017; 11:631.</a></li><li><a class="nounderline abstract_t">Cantini F, Niccoli L, Nannini C, et al. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. J Rheumatol 2017; 44:1341.</a></li><li><a class="nounderline abstract_t">Molto A, Sieper J. Peripheral spondyloarthritis: Concept, diagnosis and treatment. Best Pract Res Clin Rheumatol 2018; 32:357.</a></li><li><a class="nounderline abstract_t">Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218.</a></li><li><a class="nounderline abstract_t">Mease P, Sieper J, Van den Bosch F, et al. Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis. Arthritis Rheumatol 2015; 67:914.</a></li><li><a class="nounderline abstract_t">Schett G, Lories RJ, D'Agostino MA, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 2017; 13:731.</a></li><li><a class="nounderline abstract_t">D'Agostino MA, Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol 2006; 20:473.</a></li><li><a class="nounderline abstract_t">Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62:127.</a></li><li><a class="nounderline abstract_t">Healy PJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr Rheumatol Rep 2006; 8:338.</a></li><li><a class="nounderline abstract_t">de Winter JJ, Paramarta JE, de Jong HM, et al. Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis. RMD Open 2019; 5:e000802.</a></li><li><a class="nounderline abstract_t">Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009; 68:784.</a></li><li><a class="nounderline abstract_t">Carron P, Varkas G, Cypers H, et al. Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study. Ann Rheum Dis 2017; 76:1389.</a></li><li><a class="nounderline abstract_t">Al-Amayreh IA, Zaidat BO. Ankylosing spondylitis in Northern Jordan. Saudi Med J 2000; 21:950.</a></li><li><a class="nounderline abstract_t">Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989; 16:792.</a></li><li><a class="nounderline abstract_t">Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111:802.</a></li><li><a class="nounderline abstract_t">Van Praet L, Jacques P, Van den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol 2012; 8:288.</a></li><li><a class="nounderline abstract_t">Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23:29.</a></li><li><a class="nounderline abstract_t">De Keyser F, Baeten D, Van den Bosch F, et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002; 4:525.</a></li><li><a class="nounderline abstract_t">Cuvelier C, Barbatis C, Mielants H, et al. Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987; 28:394.</a></li><li><a class="nounderline abstract_t">Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995; 22:2279.</a></li><li><a class="nounderline abstract_t">Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Curr Rheumatol Rep 2013; 15:316.</a></li><li><a class="nounderline abstract_t">Baeten D, Breban M, Lories R, et al. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 2013; 65:12.</a></li><li><a class="nounderline abstract_t">Robinson PC, Claushuis TA, Cortes A, et al. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol 2015; 67:140.</a></li><li><a class="nounderline abstract_t">Cantini F, Nannini C, Cassarà E, et al. Uveitis in Spondyloarthritis: An Overview. J Rheumatol Suppl 2015; 93:27.</a></li><li><a class="nounderline abstract_t">Louthrenoo W. Rheumatic manifestations of human immunodeficiency virus infection. Curr Opin Rheumatol 2008; 20:92.</a></li><li><a class="nounderline abstract_t">Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol 2009; 21:404.</a></li><li><a class="nounderline abstract_t">Maganti RM, Reveille JD, Williams FM. Therapy insight: the changing spectrum of rheumatic disease in HIV infection. Nat Clin Pract Rheumatol 2008; 4:428.</a></li><li><a class="nounderline abstract_t">Winchester R, Bernstein DH, Fischer HD, et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987; 106:19.</a></li><li><a class="nounderline abstract_t">Njobvu P, McGill P. Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol 2005; 32:1299.</a></li><li><a class="nounderline abstract_t">Njobvu P, McGill P, Kerr H, et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998; 25:1553.</a></li><li><a class="nounderline abstract_t">Perez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA. Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 2016; 35:291.</a></li><li><a class="nounderline abstract_t">Resnick D, Feingold ML, Curd J, et al. Calcaneal abnormalities in articular disorders. Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and Reiter syndrome. Radiology 1977; 125:355.</a></li><li><a class="nounderline abstract_t">Olivieri I, Scarano E, Padula A, et al. Dactylitis, a term for different digit diseases. Scand J Rheumatol 2006; 35:333.</a></li><li><a class="nounderline abstract_t">Renson T, Carron P, De Craemer AS, et al. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine. Ann Rheum Dis 2021; 80:103.</a></li><li><a class="nounderline abstract_t">Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 Suppl 2:ii1.</a></li><li><a class="nounderline abstract_t">Sepriano A, Rubio R, Ramiro S, et al. Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis 2017; 76:886.</a></li><li><a class="nounderline abstract_t">Rothschild BM, Pingitore C, Eaton M. Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998; 28:41.</a></li></ol></div><div id="topicVersionRevision">Topic 7795 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21109520" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16091395" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32385142" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Peripheral spondyloarthritis: a neglected entity-state of the art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19404948" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23139267" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18817640" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22275150" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30988127" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26601781" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Similarities and differences between patients fulfilling axial and peripheral ASAS criteria for spondyloarthritis: Results from the Esperanza Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25545846" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Editorial: What is peripheral spondyloarthritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28453761" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28412702" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31171308" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Peripheral spondyloarthritis: Concept, diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1930310" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25545240" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29158573" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Enthesitis: from pathophysiology to treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16777577" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Enthesitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12525381" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Assessment of enthesitis in ankylosing spondylitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16973106" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dactylitis: pathogenesis and clinical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30713720" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19147614" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28213565" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11369960" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Ankylosing spondylitis in Northern Jordan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2778762" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Characterization of uveitis associated with spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15051216" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22508429" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The transition of acute to chronic bowel inflammation in spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8835896" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427369" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Gut inflammation and spondyloarthropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3495471" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Histopathology of intestinal inflammation related to reactive arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8835562" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23371481" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Psoriatic arthritis: phenotypic variance and nosology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23288559" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25200001" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26523051" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Uveitis in Spondyloarthritis: An Overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18281864" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Rheumatic manifestations of human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19444116" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18577999" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Therapy insight: the changing spectrum of rheumatic disease in HIV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3789575" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The co-occurrence of Reiter's syndrome and acquired immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15996068" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Human immunodeficiency virus related reactive arthritis in Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9712100" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Spondyloarthropathy and human immunodeficiency virus infection in Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26573206" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/910045" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Calcaneal abnormalities in articular disorders. Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and Reiter syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17062430" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Dactylitis, a term for different digit diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33115761" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19433414" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28179264" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9726335" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Dactylitis: implications for clinical practice.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
